Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women

Inclusion Criteria:

• Submission of a signed and dated informed consent form.

• Declared willingness to comply with all study procedures and availability for theduration of the study.

• Can read and write

• Female, age 45 to 65 years

• Female with more than 1 year of amenorrhea.

• No hormone replacement therapy or herbal medications in the 6 months prior to theinvestigation.

• Ability to take oral medication and willing to comply with the <study interventionregimen.

• Agreement to comply with Lifestyle Considerations for the duration of the study.

• Have a smartphone-type cell phone

• Residence in Francisco Morazán

Exclusion Criteria:

• Patient does not sign informed consent

• Patient does not wish to participate

• History of thrombo embolism

• History of cardiovascular disease

• Presence of estrogen-dependent neoplasm

• Presence of abnormal genital bleeding

• Uncontrolled metabolic diseases

• Smoking and drinking habits

• Use of anticoagulant or acetylsalicylic acid

• Known allergic reactions to soy isoflavonate components

• History of thrombophilias such as: Antithrombin deficiency, Protein C deficiency,Protein S deficiency, Factor V Leiden, Prothrombin G20210A, Hyperhomocysteinemia,Antiphospholipid syndrome, Acquired activated protein C resistance.